-
Projected Rapid-Growing Economic Burden of Chronic Respiratory Multimorbidity in Singapore: Unveiling Diagnostic Gaps and Asian Phenotypes Through Health Administrative Data
Sep 9, 2025, 16:22 PM -
Global Access to Innovative Medicines in 2025: Europe’s Gaps and the UK’s Continued Decline
Sep 9, 2025, 16:22 PM -
Impact of Anosmia Severity on Health Utility Values in Chronic Rhinosinusitis With Nasal Polyps: An Exploratory Analysis From the WAYPOINT Trial
Sep 9, 2025, 16:22 PM -
Healthcare Expenditure for Treatment of Cardiovascular Disease Among Hypercholesterolemia Patients in Japan: A Claims Data Analysis
Sep 9, 2025, 16:22 PM -
Structural Uncertainty (SU) in Model-Based Economics Appraisal (MBEA): A Document Review of the French National Authority for Health (HAS)
Sep 9, 2025, 16:22 PM -
From Diagnosis to Treatment: Evaluating Timeliness and Treatment Patterns in Czech Pancreatic Cancer Patients
Sep 9, 2025, 16:22 PM -
Budget Impact of a Minimally Invasive Surgical Treatment for Benign Prostatic Obstruction in Italian Healthcare Service
Sep 9, 2025, 16:22 PM -
The Health Impact of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab Treatment for High-Risk Early Stage Triple-Negative Breast Cancer (eTNBC) in Türkiye
Sep 9, 2025, 16:22 PM -
Real-World Evidence of Atezolizumab in Unresectable Recurrent NSCLC: Insights From Japan's Next-Generation Medical Infrastructure Act
Sep 9, 2025, 16:22 PM -
An Adjusted Indirect Comparison of Once-Weekly Insulin Efsitora Alfa vs. Insulin Icodec for Adults With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin
Sep 9, 2025, 16:22 PM -
Maximizing Profits Through Pricing: Opportunities in Portugal's Pharma Sector
Sep 9, 2025, 16:22 PM -
Bridging the Gap: What Spain Can Learn From European Leaders in Digital Therapy Reimbursement
Sep 9, 2025, 16:22 PM -
Challenges and Opportunities in the Dutch Lock Procedure Improving Access and Reimbursement Timelines for Cell and Gene Therapies in the Netherlands
Sep 9, 2025, 16:22 PM -
Are We There Yet? Mapping Member State Readiness for Local Implementation of the EU Health Technology Assessment (HTA) Regulation
Sep 9, 2025, 16:22 PM -
Early Economic Modeling of Mutant TNF (mutTNF) As a BBB-Permeabilizing Adjunct in Breast Cancer Brain Metastases: A UK NHS Perspective
Sep 9, 2025, 16:22 PM -
Sex Differences in Chronic Hand Eczema (CHE) Triggering Factors: Comorbidities, Lifestyle, and Exposures Findings From a Multinational Study in Six Countries
Sep 9, 2025, 16:22 PM -
AI for Precision Oncology Evidence: Case Study Research From British Columbia, Canada
Sep 9, 2025, 16:22 PM -
Challenges in PICO Definition for HTDs: Lessons From Durvalumab Exercise
Sep 9, 2025, 16:22 PM -
Inter-Version Comparison of the Boston Carpal Tunnel Questionnaire: A Clinical Validation Study of the Decision Tree-Based Version
Sep 9, 2025, 16:22 PM -
Pain and Fatigue Assessment and Evaluation in Oncology Trials
Sep 9, 2025, 16:22 PM
